| Title |
-
en
Knockdown of legumain inhibits cleavage of annexin A2 in the mouse kidney
|
| Creator |
|
| Accessrights |
open access |
| Subject |
-
Other
en
Legumain
-
Other
en
Annexin A2
-
Other
en
Cationic liposome
-
Other
en
siRNA
-
Other
en
In vivo
-
Other
en
Mouse kidney
-
NDC
491
|
| Description |
-
Abstract
en
Legumain (EC 3.4.22.34) is an asparaginyl endopeptidase. Strong legumain activity was observed in the mouse kidney, and legumain was highly expressed in tumors. We previously reported that bovine kidney annexin A2 was co-purified with legumain and that legumain cleaved the N-terminal region of annexin A2 at an Asn residue in vitro. In this study, to determine whether annexin A2 is cleaved by legumain in vivo, siRNA-lipoplex targeting mouse legumain was injected into mouse tail veins. Mouse kidneys were then isolated and the effect of knockdown of legumain expression on annexin A2 cleavage was examined. The results showed that both legumain mRNA and protein expression levels were decreased in the siRNA-treated mouse kidneys and that legumain activity toward a synthetic substrate, Z-Ala-Ala-Asn-MCA, was decreased by about 40% in the kidney but not in the liver or spleen. Furthermore, cleavage of annexin A2 at the N-terminal region was decreased in the mouse kidney that had been treated with the legumain siRNA-lipoplex. These results suggest that legumain siRNA was delivered to the kidney by using LipoTrust and that the reduced legumain expression inhibited legumain-induced degradation of annexin A2 in vivo. (C) 2012 Elsevier Inc. All rights reserved.
|
| Publisher |
en
ACADEMIC PRESS INC ELSEVIER SCIENCE
|
| Date |
|
| Language |
|
| Resource Type |
journal article |
| Version Type |
AM |
| Identifier |
HDL
http://hdl.handle.net/2115/52625
|
| Relation |
-
isVersionOf
DOI
https://doi.org/10.1016/j.bbrc.2012.12.010
-
PMID
23237799
|
| Journal |
-
-
en
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
-
Volume Number430
Issue Number2
Page Start482
Page End487
|
| File |
|
| Oaidate |
2023-07-26 |
